LON: CIZ Statistics

Total Valuation

Cizzle Biotechnology Holdings has a market cap or net worth of GBP 6.94 million. The enterprise value is 6.12 million.

Market Cap	6.94M
Enterprise Value	6.12M

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Cizzle Biotechnology Holdings has 396.39 million shares outstanding. The number of shares has increased by 12.73% in one year.

Current Share Class	n/a
Shares Outstanding	396.39M
Shares Change (YoY)	+12.73%
Shares Change (QoQ)	+3.95%
Owned by Insiders (%)	22.09%
Owned by Institutions (%)	40.83%
Float	305.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	8.34
P/TBV Ratio	8.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.27
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.16

Current Ratio	7.16
Quick Ratio	7.16
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -157.81% and return on invested capital (ROIC) is -34.12%.

Return on Equity (ROE)	-157.81%
Return on Assets (ROA)	-31.72%
Return on Capital (ROIC)	-34.12%
Revenue Per Employee	n/a
Profits Per Employee	-674,250
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.45% in the last 52 weeks. The beta is 0.38, so Cizzle Biotechnology Holdings's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	-20.45%
50-Day Moving Average	1.89
200-Day Moving Average	1.84
Relative Strength Index (RSI)	34.89
Average Volume (20 Days)	892,831

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-933,000
Pretax Income	-2.73M
Net Income	-2.70M
EBITDA	n/a
EBIT	-933,000
Earnings Per Share (EPS)	-0.01

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	816,000
Total Debt	n/a
Net Cash	816,000
Net Cash Per Share	0.00
Equity (Book Value)	794,000
Book Value Per Share	0.00
Working Capital	794,000

Full Balance Sheet

Cash Flow

Operating Cash Flow	-550,000
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cizzle Biotechnology Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.73%
Shareholder Yield	-12.73%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a